Search by Drug Name or NDC

    NDC 00002-0213-01 Humulin 100 [iU]/mL Details

    Humulin 100 [iU]/mL

    Humulin is a PARENTERAL INJECTION, SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN HUMAN.

    Product Information

    NDC 00002-0213
    Product ID 0002-0213_458ef2aa-cd5f-48bc-8829-82420cfed33b
    Associated GPIs
    GCN Sequence Number 001723
    GCN Sequence Number Description insulin regular, human VIAL 100/ML INJECTION
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 11642
    HICL Sequence Number 000768
    HICL Sequence Number Description INSULIN REGULAR, HUMAN
    Brand/Generic Brand
    Proprietary Name Humulin
    Proprietary Name Suffix R
    Non-Proprietary Name Insulin human
    Product Type HUMAN OTC DRUG
    Dosage Form INJECTION, SOLUTION
    Route PARENTERAL
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN HUMAN
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin [CS], Insulin [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA018780
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-0213-01 (00002021301)

    NDC Package Code 0002-0213-01
    Billing NDC 00002021301
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (0002-0213-01) / 3 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2023-06-20
    NDC Exclude Flag N
    Pricing Information N/A